Schonfeld Strategic Advisors LLC Corcept Therapeutics Inc Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 11,346 shares of CORT stock, worth $555,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,346Holding current value
$555,046% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding CORT
# of Institutions
315Shares Held
88.3MCall Options Held
1.07MPut Options Held
973K-
Black Rock Inc. New York, NY16.5MShares$809 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$467 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$403 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$338 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$187 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.24B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...